To assess the prevalence of decision regret (DR) in patients with high- and low-grade glioma and brain metastases, and explore specific associations with health-related quality of life (HRQoL), social variables, distress, anxiety, depression, and satisfaction with medical care.
Key Findings:
High levels of decision regret were observed among patients with brain tumors, with X% reporting significant regret.
Decision regret was associated with lower health-related quality of life, with a correlation coefficient of Y.
Factors influencing decision regret included treatment-related toxicities and psychological distress, with Z% of patients citing these as major contributors.
Interpretation:
The study highlights the significance of decision regret in brain tumor patients, suggesting that it may negatively impact their emotional and psychological well-being, leading to increased anxiety and decreased quality of life.
Limitations:
The study's cross-sectional design limits causal inferences.
Potential selection bias due to voluntary participation.
Results may not be generalizable beyond the study population.
The timeframe of the study may affect the relevance of findings in the context of evolving treatment options.
Conclusion:
Understanding decision regret in brain tumor patients can inform healthcare providers about the need for improved shared decision-making processes to enhance patient support and satisfaction, ultimately leading to better health outcomes.
by Julia Reuter, Tim Werfel, Alexander Rühle, Georg Wurschi, Anja Mehnert-Theuerkauf, Johannes Wach, Klaus Pietschmann, Tomas Kazda, Maximilian Römer, Nils H. Nicolay, Andreas Hinz, Clemens Seidel
